The effort to find ways to detect and diagnose preclinical Alzheimer’s disease (AD) has taken a big step forward with the use of positron emission tomography (PET), a “nuclear medicine” for imaging processes in the body, when PET is used with a special ‘tracer’ that binds to the amyloid plaques in the brain that are a characteristic cause of AD.
from Dementia Big http://ift.tt/25eegGa via alcoholic dementia
http://ift.tt/20Adobn
No comments:
Post a Comment